Vivos Inc (RDGL)

[druidfish]

SHORT TERM THERE ARE TWO PATHS FOR ADMD and both point to a lower stock price.

1) They must raise money to start the resubmission process, to pay licensing fees, to expand overseas, all those things that posters here say are coming. To do this they start diluting to the tune of several billion more shares issued. This dilution was promised by the CEO, it’s not simply my opinion. I do not see how they do that at these price levels so there may be a large reverse split coming.

That’s the positive scenario, OR they could

2) Simply throw in the towel as they have repeatedly warned in their SEC filings, declaring that, should the FDA reject the de novo, it is doubtful they could continue. They have so many issues stacked against them such as loan defaults, lawsuits, inability to raise funds, no employees to speak of, that Jim may deem it easier to fold up shop and move on to his next scheme. After all, Jim has already sucked millions out of shareholders through a $250,000 salary plus bonuses, and please, don’t tell me how concerned Jim is with the welfare of shareholders.

In either case the outcome will be a large percentage loss for current shareholders. One scenario allows them to survive, the other does not.

If anyone has a third alternative, I’d like to hear it. Something beyond, “Jim says they are looking into XXXX or whatever.” Something with concrete facts not vague promises and dreams or statements about knowing something the rest of us do not know.

They apparently have a good product but, IMO, their share structure and horrid financial condition leaves little room for hope.